TEAM


Robert Swartz

Chairman & Founder

+ Read More - Close

Bob Swartz is an inventor and businessman and began developing Impossible Objects’ technology in 2009. Concurrently, and for over ten years, Bob has been a consultant on intellectual property at the MIT Media Laboratory. He has founded and operated a number of companies, including: a software company that developed a complete version of Unix and C Compilers licensed by a number of major computer corporations including Intel and Digital Equipment Corporation; a multi-million dollar advertising display manufacturing company; a telephony company; and patent licensing companies through which he has licensed his own patents to major corporations such as AT&T, Comcast and Verizon. Mr. Swartz studied mathematics as an undergraduate and was a graduate student in mathematics at MIT and University of Chicago and in computer science at Northwestern University.


Gintaras Vaisnys

Chief Executive Officer

+ Read More - Close

Gintaras Vaisnys has been involved with Impossible Objects since 2016, first as a major investor, then as a consultant. Gintaras assumed the role of CEO in 2018.

Most recently, Gintaras was co-founder, CEO/President and board member of Defibtech, LLC, a leading innovator and manufacturer of Automated External Defibrillators (AEDs). The company has sold more than 350,000 defibrillators and more than 1,000,000 disposables in over 40 countries around the world and was named as the fastest growing medical device company in the United States (7th overall) in the 2007 Deloitte "Fast 500" list. Defibtech was sold to Nihon Kohden, a leading Japanese medical device firm, in 2012. Gintaras remained on as CEO through 2017.

Defibtech and the products that Gintaras has personally helped design have won Medical Device Excellence awards (2005, 2011), IDSA (Industrial Designers Society of America) awards (2013 and 2004: IDEA awards; 2010: Design of the Decade), and numerous other product and business awards. One of his designs was exhibited at the MoMA (“Design Takes on Risk”, Museum of Modern Art, NYC). Gintaras is a graduate of Yale University (BS, Engineering) and holds more than 40 patents.


Jeff DeGrange

Chief Commercial Officer

+ Read More - Close

Jeff DeGrange joined the Company as Chief Commercial Officer in April 2015. Jeff is a former Vice President at Stratasys, a worldwide provider of 3D printing technologies and services. Prior to Stratasys, Jeff was with the Boeing Company where he led the certification and qualification of flight hardware built with different additive manufacturing technologies for the F/A-18 Super Hornet and 787 aircraft programs and advanced manufacturing initiatives. Jeff is one of the founders and past chairman of the Direct Manufacturing Research Center (DMRC) at Paderborn University in Germany and serves on several industry advisory boards. Jeff has a B.S. in Industrial Engineering from the University of Iowa and an M.S. in Mechanical Engineering from Washington University in St. Louis.


Dr. John Bayldon

Chief Composite Scientist

+ Read More - Close

John Bayldon joined the Company as Chief Manufacturing Officer in July 2014 and previously had been a consultant to the Company specializing in manufacturing and mechanics of composite materials. Dr. Bayldon holds an MSc in composite materials and engineering from Imperial College London and a PhD in Theoretical and Applied Mechanics from Northwestern University. Dr. Bayldon’s early career included production and technical management positions in manufacturing companies. He subsequently worked as a principal researcher and as Technology Chief for Composite Manufacturing for the UK’s Defense Research and Evaluation agency in their Farnborough laboratories. Since moving to the U.S. in 2001 (in addition to earning his doctorate), Dr. Bayldon worked as a consultant helping set up the Canadian National Research Center’s Advanced Manufacturing Technology Center in Montreal, and helping the FAA in developing guidance for the certification of composite materials in aircraft structures.